Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Woyach

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Oncology (Williston Park, N.Y.)|June 26, 2018
Counterpoint: Does Chemoimmunotherapy Still Have a Role in CLL? Chemotherapy Can Be Eliminated in the Management of CLLJennifer A Woyach
Clinical Advances in Hematology & Oncology : H&O|April 17, 2026
The sequencing of covalent and noncovalent BTK inhibitors in CLLJennifer A Woyach
Blood|May 11, 2013
Survival of the weak (signalers): anergy in CLLJennifer A Woyach
Best Practice & Research. Clinical Haematology|February 18, 2018
What is the optimal management of older CLL patients?Jennifer A Woyach
Blood|January 16, 2016
FCR holds up to the test of time: CLL8 follow-upJennifer A Woyach
American Journal of Hematology|September 20, 2022
Management of relapsed/refractory Chronic Lymphocytic LeukemiaJennifer A Woyach
Blood|November 22, 2019
Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trialsJennifer A Woyach
Clinical Advances in Hematology & Oncology : H&O|July 8, 2021
Mechanisms of resistance to BTK inhibitors in patients with chronic lymphocytic leukemiaJennifer A Woyach
Blood|November 3, 2018
Ibrutinib and <i>Aspergillus:</i> a Btk-targeted riskJennifer A Woyach
Journal of Geriatric Oncology|September 19, 2019
Making clinical trials work for older patients with chronic lymphocytic leukemiaJennifer A Woyach
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Oncology (Williston Park, N.Y.)|June 26, 2018
Counterpoint: Does Chemoimmunotherapy Still Have a Role in CLL? Chemotherapy Can Be Eliminated in the Management of CLLJennifer A Woyach
Clinical Advances in Hematology & Oncology : H&O|April 17, 2026
The sequencing of covalent and noncovalent BTK inhibitors in CLLJennifer A Woyach
Blood|May 11, 2013
Survival of the weak (signalers): anergy in CLLJennifer A Woyach
Best Practice & Research. Clinical Haematology|February 18, 2018
What is the optimal management of older CLL patients?Jennifer A Woyach
Blood|January 16, 2016
FCR holds up to the test of time: CLL8 follow-upJennifer A Woyach
American Journal of Hematology|September 20, 2022
Management of relapsed/refractory Chronic Lymphocytic LeukemiaJennifer A Woyach
Blood|November 22, 2019
Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trialsJennifer A Woyach
Clinical Advances in Hematology & Oncology : H&O|July 8, 2021
Mechanisms of resistance to BTK inhibitors in patients with chronic lymphocytic leukemiaJennifer A Woyach
Blood|November 3, 2018
Ibrutinib and <i>Aspergillus:</i> a Btk-targeted riskJennifer A Woyach
Journal of Geriatric Oncology|September 19, 2019
Making clinical trials work for older patients with chronic lymphocytic leukemiaJennifer A Woyach
Pageof 19